Zydus Lifesciences launches generic drug for overactive bladder in US market

The company has launched Mirabegron extended-release tablets in strength of 25 mg in the US market after having received final approval from the US Food and Drug Administration (USFDA), Zydus Lifesciences said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/sgYX1vc